Cited by 349HER2/EGFR in Cancer ResearchFibroblast Growth Factor ResearchGrowth Hormone and Insulin-like Growth Factors

Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein

Open access
Higashiyama, S, Lau, K, Besner, G.E., Abraham, J.A., Klagsbrun, M·1992·Journal of Biological Chemistry

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a newly described member of the epidermal growth factor (EGF) family that is mitogenic for BALB/c 3T3 cells, inhibits the binding of 125I-EGF to its receptor, and triggers autophosphorylation of the EGF receptor. HB-EGF was purified from the conditioned medium of U-937 cells using cation exchange, copper affinity, heparin affinity, and two rounds of C4 reversed phase liquid chromatography. The elution profile of the first round of C4 column chromatography contained four growth factor activity peaks with similar specific biological activities. N-terminal and tryptic fragment microsequencing demonstrated that these peaks contained different structural forms of the HB-EGF protein. Some of the differences in the various forms of HB-EGF were found to be due to N-terminal heterogeneity. Microsequencing of tryptic fragments indicated that the mature HB-EGF polypeptide can contain at least 86 of the 208 amino acids predicted by nucleotide sequence to be the HB-EGF precursor molecule. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis indicated that the various forms of HB-EGF have apparent molecular masses of 19-23 kDa. Further analysis of the most predominant form of HB-EGF found in U-937 cell conditioned medium indicated that it has a pI of 7.2-7.8 and is O-glycosylated.

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(18)42682-8

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • pro-HB-EGF is made as a transmembrane protein and metalloproteinases can cleave it in a juxtamembrane domain to release soluble HB-EGF.

    “It is first synthesized as a transmembrane protein (pro-HB-EGF) and can be cleaved by metalloproteinases (MMPs) within a juxtamembrane domain on the cell surface to release soluble HB-EGF (Higashiyama et al., 1991; Higashiyama et al., 1992; Higashiyama and Nanba, 2005).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Higashiyama, S., Lau, K., Besner, G. E., Abraham, J. A., & Klagsbrun, M.
Affiliations
Harvard University (US)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1992-03
Volume
267
Issue
9
Pages
6205-6212
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1514034386
Cited by
349
References
30
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 2 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 1 · 2017: 2 · 2016: 5 · 2015: 12 · 2014: 10 · 2013: 8 · 2012: 10
FWCI
12.27
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (P01CA045548, CA 37392, CA-45548)
Topics
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
HB-EGF, epidermal growth factor family, protein structure, O-glycosylation, mitogenic activity, U937 cells, protein purification, primary structure
MeSH terms
Amino Acid Sequence, Animals, Antibodies, Biological Assay, Cell Line, Chromatography, Affinity, Chromatography, High Pressure Liquid, DNA Replication, Electrophoresis, Polyacrylamide Gel, Epidermal Growth Factor, Glycosylation, Growth Substances, Heparin, Humans, Isoelectric Focusing, Molecular Sequence Data, Molecular Weight, Peptide Fragments, Peptide Mapping, Platelet-Derived Growth Factor, Sequence Homology, Nucleic Acid, 3T3 Cells, Intercellular Signaling Peptides and Proteins, Mice, Heparin-binding EGF-like Growth Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review